Isomorphic Labs · Company profile
Isomorphic Labs · 英国/美国 · AI, models, and data
Registered focus: AI药物设计、蛋白结构、生成模型. Focus is directory metadata; inspect the sources and project evidence below to assess specific capabilities.
Public reviewed developments
Isomorphic Labs 加入 Virtual Biology Initiative
Wed Oct 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Isomorphic Labs 官方公告，加入由 Biohub 召集的 Virtual Biology Initiative，参与组织将投入数据、计算与测量技术。Biohub 尚未完成本库实体归属核验，暂不绘制关系边。
Isomorphic Labs 宣布完成 21 亿美元 B 轮融资
Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Isomorphic Labs 官方公告，已完成 21 亿美元 B 轮融资。当前证据说明融资公告，不证明药物研发成效。
Isomorphic Labs 与强生宣布跨模态、多靶点研究合作
Tue Jan 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Isomorphic Labs 官方公告，与 Johnson & Johnson 开展研究合作，结合 AI 药物发现与药物开发能力。此公告中的强生集团暂不强行归为本库某个业务实体。
Collaboration, licensing, and acquisition timeline
Isomorphic Labs 加入 Virtual Biology Initiative
Wed Oct 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Isomorphic Labs 官方公告，加入由 Biohub 召集的 Virtual Biology Initiative，参与组织将投入数据、计算与测量技术。Biohub 尚未完成本库实体归属核验，暂不绘制关系边。
Isomorphic Labs 与强生宣布跨模态、多靶点研究合作
Tue Jan 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Isomorphic Labs 官方公告，与 Johnson & Johnson 开展研究合作，结合 AI 药物发现与药物开发能力。此公告中的强生集团暂不强行归为本库某个业务实体。
These are drawn from the latest 3 reviewed developments. A collaboration, model performance, experimental results, and clinical progress each require their own evidence.
Public source records
Isomorphic Labs joins the Virtual Biology Initiative to build foundational data for AI models to predict and treat disease
Isomorphic Labs official announcements · Indexed industry source record · Source published: Wed Oct 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:07:57 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts Convened by Biohub, participating organisations are investing funding, data, computation and new measurement technology - the largest coordinated commitment to generating AI-ready biologica
Building a new path to make medicines with AI
Isomorphic Labs official announcements · Indexed industry source record · Source published: Tue Sep 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:09 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts The Scale Solving all disease is one of the most monumentally complex challenges in science. Today, for the first time, AI provides the foundation to make it achievable. Tackling the fronti
Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine
Isomorphic Labs official announcements · Indexed industry source record · Source published: Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 08:27:55 GMT+0000 (Coordinated Universal Time)
Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine an AI-first drug design and development company, today announced it has raised $2.1 Billion in Series B funding
Isomorphic Labs announces Series B investment round
Isomorphic Labs official announcements · Indexed industry source record · Source published: Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:33 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts Isomorphic Labs announces it has raised $2.1 Billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alon
Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson
Isomorphic Labs official announcements · Indexed industry source record · Source published: Tue Jan 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:46 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts Isomorphic Labs announces a cross-modality, multi-target research collaboration with Johnson & Johnson. This partnership brings together Iso’s AI-first approach to drug discovery with Johns
Isomorphic Labs to appoint Max Jaderberg as President
Isomorphic Labs official announcements · Indexed industry source record · Source published: Wed Nov 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:54 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts Isomorphic Labs announces the appointment of Max Jaderberg as President of the company effective 1 January 2026, transitioning from his current role as Isomorphic Labs’ Chief AI Officer. Co
Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence
Isomorphic Labs official announcements · Indexed industry source record · Source published: Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:05 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts Isomorphic Labs appoints Dr. Ben Wolf M.D., Ph.D., as Chief Medical Officer and establishes US Presence. Dr. Wolf will be based in the company's newly established Cambridge location, where
Isomorphic Labs announces $600m external investment round
Isomorphic Labs official announcements · Indexed industry source record · Source published: Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:23 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts Isomorphic Labs announces it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital fro
Verified official and subscription sources
- Isomorphic Labs official announcements · Collection enabled · Last successful collection Fri Oct 09 2026 07:09:18 GMT+0000 (Coordinated Universal Time)
Source verification and ongoing collection are shown separately. Indexed source records do not automatically become reviewed events.
Reader guides: from sources to conclusions
Compare models by task and follow collaborations through evidence. Each guide includes original sources and a review date.
How should we compare virtual cells, AI models, and companies?
Compare single-cell models, structure prediction, and protein design by inputs, outputs, tasks, and validation conditions. Distinguish model papers from company capabilities.
Reader guide · updated 2026-10-08
AI drug discovery collaboration timelines: from announcements to evidence
Use real official announcements to distinguish partners, upfront payments, conditional milestones, and R&D progress, and build a traceable collaboration timeline.
Reader guide · updated 2026-10-08
How to read weekly AI drug discovery updates: companies, research, and coverage gaps
Build a weekly reading routine, distinguish announcements, papers, and clinical results, and understand this site’s weekly indexing window, denominators, and source coverage.
Reader guide · updated 2026-10-08